Neurobo Pharmaceuticals Inc (NASDAQ:NRBO)
| 0.73 Delayed Data As of Mar 29 |  +0.02 / +2.82%Today’s Change | 0.55 Today|||52-Week Range 63.85 | +1.74% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Expenses | Gross Income | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| General Expenses | 7.2M | 14.7M | 33.1M | 22.8M | ||
| Research And Development | 4.0M | 8.7M | 22.7M | 14.3M | ||
| Total Operating Expenses | 7.2M | 14.7M | 33.1M | 22.8M | ||
| Non-Operating Expenses | Operating Income | -7.2M | -14.7M | -33.1M | -22.8M | |
| Extraordinary Credit | 0.00 | 200.0K | 0.00 | 0.00 | ||
| Extraordinary Charge | -1.5M | 0.00 | 0.00 | -200.0K | ||
| Interest Expense On Debt | 362.0K | 86.0K | 328.0K | 854.0K | ||
| Other Expenses | 7.0K | -4.0K | -5.0K | 22.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -9.0M | -14.6M | -33.4M | -23.6M | |
| Preferred Dividend | -4.0M | -366.0K | 0.00 | 0.00 | ||
| Net Income | -9.0M | -14.6M | -33.4M | -23.6M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 9.0M | 5.8M | 10.3M | 13.8M | |
| Shares To Calculate EPS Diluted | 9.0M | 5.8M | 10.3M | 13.8M | ||
| Earnings Per Share | EPS | -$1.45 | -$2.57 | -$3.23 | -$1.71 | |
| EPS Diluted | -$1.45 | -$2.57 | -$3.23 | -$1.71 | ||
